Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
S&G Biotech is a South Korean medical device company that specializes in the development and manufacturing of vascular and non-vascular stents. Founded in 2000, the company has established a significant presence in the interventional radiology and gastroenterology markets with its proprietary SEAL Stent technology. Their product portfolio includes a wide range of self-expanding metal stents (SEMS) designed for biliary, esophageal, tracheal, and colorectal applications, as well as specialized vascular grafts. S&G Biotech focuses on providing minimally invasive solutions for luminal obstructions and vascular disorders, leveraging advanced nitinol braiding and coating technologies. The company maintains global distribution networks and is recognized for its high-quality manufacturing standards in the medical device sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S&G Properties.